| Title |
Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
|
|---|---|
| Published in |
Diabetologia, March 2007
|
| DOI | 10.1007/s00125-007-0633-0 |
| Pubmed ID | |
| Authors |
V. Fonseca, A. Schweizer, D. Albrecht, M. A. Baron, I. Chang, S. Dejager |
| Abstract |
Type 2 diabetes is difficult to manage in patients with a long history of disease requiring insulin therapy. Moreover, addition of most currently available oral antidiabetic agents increases the risk of hypoglycaemia. Vildagliptin is a dipeptidyl peptidase-IV inhibitor, which improves glycaemic control by increasing pancreatic beta cell responsiveness to glucose and suppressing inappropriate glucagon secretion. This study assessed the efficacy and tolerability of vildagliptin added to insulin therapy in patients with type 2 diabetes. |
Mendeley readers
The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | <1% |
| Unknown | 105 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 21% |
| Other | 15 | 14% |
| Student > Master | 14 | 13% |
| Student > Bachelor | 12 | 11% |
| Student > Ph. D. Student | 10 | 9% |
| Other | 16 | 15% |
| Unknown | 17 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 49% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 10% |
| Agricultural and Biological Sciences | 10 | 9% |
| Nursing and Health Professions | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Other | 5 | 5% |
| Unknown | 20 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2015.
All research outputs
#4,630,461
of 22,919,505 outputs
Outputs from Diabetologia
#1,968
of 5,045 outputs
Outputs of similar age
#14,318
of 77,014 outputs
Outputs of similar age from Diabetologia
#7
of 31 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,045 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.7. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 77,014 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.